Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
20,941,617
-
Share change
-
-2,483,511
-
Total reported value
-
$482,311,923
-
Put/Call ratio
-
20%
-
Price per share
-
$23.05
-
Number of holders
-
83
-
Value change
-
-$39,648,327
-
Number of buys
-
52
-
Number of sells
-
42
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q3 2016
As of 30 Sep 2016,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,941,617 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, Sectoral Asset Management Inc, venBio Select Advisor LLC, Foresite Capital Management III, LLC, BlackRock Fund Advisors, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.